Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Jingtao Huang, Jing Zhou, Shixuan Zhang, Ruoxuan Zhang, Zengkai Pan, Luxiang Wang, Chuanhe Jiang, Jiayu Huang, Zilu Zhang, Yanmin Zhao, Yang Cao, Jianmin Wang, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 268.

https://doi.org/10.1182/blood-2024-202762

Published: 2024

Journal Articles

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Zengkai Pan, Yujun Deng, Jingtao Huang, Aijie Huang, Xiong Ni, Lei Gao, Chuanhe Jiang, Luxiang Wang, Zilu Zhang, Quan Gu, Hui Cheng, Jianmin Wang, Hongbo Hu, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 101.

https://doi.org/10.1182/blood-2024-200811

Published: 2024

Journal Articles

Checkpoint Immunotherapy Is Associated with Preferential Activation of Tumor-Antigen Specific CD4 + T Cells in MDS

Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Krista Belko, Amanda C. Przespolewski, Eunice S. Wang, Prashant Singh, Jianmin Wang, Michael J. Nemeth

Blood (2023) 142 (Supplement 1): 4602.

https://doi.org/10.1182/blood-2023-178756

Published: 2023

Journal Articles

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

Zengkai Pan, Yujun Deng, Aijie Huang, Zilu Zhang, Luxiang Wang, Hongbo Hu, Jianmin Wang, Xiaoxia Hu

Blood (2022) 140 (Supplement 1): 7636–7637.

https://doi.org/10.1182/blood-2022-165074

Published: 2022

Journal Articles

β2-AR Signaling Enhances MDSC Survival through Metabolic Reprograming and Impairs Therapeutic Efficacy in Hematologic Malignancies

Saeed Daneshmandi, Cameron R. MacDonald, Manu Pandey, Jee Eun Choi, Nathan Roberts, Suzanne M Hess, Teresa W.M. Fan, Richard M. Higashi, Andrew N. Lane, Prashant Singh, Jianmin Wang, Philip L. McCarthy, Elizabeth A. Repasky, Hemn Mohammadpour

Blood (2022) 140 (Supplement 1): 8867–8869.

https://doi.org/10.1182/blood-2022-167654

Published: 2022

Journal Articles

Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia

Chengjuan Luo, Shaoyan Hu, Xiaoqin Feng, Jun Lu, Hua Zhu, Yongsheng Ruan, Jing Ling, Changying Luo, Jianmin Wang, Yuanyuan Tian, Bohan Li, Wing H. Leung, Jing Chen

Blood (2022) 140 (Supplement 1): 10458–10459.

https://doi.org/10.1182/blood-2022-165009

Published: 2022

Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Xiaoxia Hu, Aijie Huang, Qi Chen, Ying Zhang, Lixia Liu, Chengcheng Wang, Weiping Zhang, Jianmin Yang, Jianmin Wang

Blood (2019) 134 (Supplement_1): 2713.

https://doi.org/10.1182/blood-2019-129186

Published: 2019

Journal Articles

Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141 Hi Conventional Dendritic Cells

Pragya Srivastava, PhD, Stephanie Tzetzo, Eduardo Cortes Gomez, Kevin Eng, Prashant K Singh, PhD, Kitty De Jong, Sheila N. J. Sait, PhD, Kyle Wiatrowski, Miranda L Lynch, PhD, Jennifer Peresie, BS, Jianmin Wang, PhD, Elizabeth A. Griffiths, MD, Michael J. Nemeth, PhD

Blood (2019) 134 (Supplement_1): 1695.

https://doi.org/10.1182/blood-2019-126220

Published: 2019

Journal Articles

RNA Editing By APOBEC3A Confers Dynamic Mutational Load in Monocytic Leukemias

Bora E Baysal, MD PhD, Shraddha Sharma, PhD, Jianmin Wang, PhD, Eduardo Cortes-Gomez, M.S, Scott Portwood, MS, Eunice S. Wang, MD

Blood (2017) 130 (Supplement 1): 3939.

https://doi.org/10.1182/blood.V130.Suppl_1.3939.3939

Published: 2017

Journal Articles

Patients with MDS Demonstrate Reduced Numbers and Impaired Differentiation of CD141 Hi Conventional Dendritic Cells

Pragya Srivastava, PhD, Elizabeth A. Griffiths, MD, Prashant Singh, PhD, Eduardo Cortes Gomez, BS, Eunice S. Wang, MD, LaurieAnn Ford, BS, Jianmin Wang, PhD, Michael J. Nemeth, PhD

Blood (2017) 130 (Supplement 1): 2955.

https://doi.org/10.1182/blood.V130.Suppl_1.2955.2955

Published: 2017

Journal Articles

Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leukemia Patients with Imatinib-Resistance or -Intolerance: Results from a 6-Year Follow-up of a Multicenter Phase II Study

Xiaojun Huang, Qian Jiang, MD, Jianda Hu, MD PhD, Jianyong Li, Jie Jin, MD PhD, Fanyi Meng, Zhixiang Shen, MD, Ting Liu, Depei Wu, MDPhD, Jianmin Wang, Jianxiang Wang

Blood (2016) 128 (22): 1928.

https://doi.org/10.1182/blood.V128.22.1928.1928

Published: 2016

Journal Articles

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Xiong Ni, MD, Qingxiao Song, MD, Ruishu Deng, MD PhD, Hua Jin, BS, Kaniel M. Cassady, BS, Mingfeng Zhang, PhD, Stephen J. Forman, MD, Paul J. Martin, MD, Jianmin Wang, MD PhD, Defu Zeng, MD

Blood (2015) 126 (23): 1882.

https://doi.org/10.1182/blood.V126.23.1882.1882

Published: 2015

Journal Articles

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Blood (2015) 125 (18): 2771–2778.

https://doi.org/10.1182/blood-2014-09-601674

Published: 2015

Journal Articles

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Renchi Yang, MD, Ming Hou, MD, Junmin Li, MD PhD, Jie Jin, MD, Meijuan Huang, MD, Ziqiang Yu, MD, Xiaojun Xu, Xiaohui Zhang, Xin Du, MD, Ting Niu, MD PhD, Xiaoyan Ke, MD PhD, Jianmin Wang, MD PhD, Jing Liu, MD, Jing Sun, MD, Yongqiang Zhao, MD& PhD, Hua Lu, MD, Haiyi Guo, MD, Belinda Hsu, Senior statistician

Blood (2014) 124 (21): 1464.

https://doi.org/10.1182/blood.V124.21.1464.1464

Published: 2014

Journal Articles

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Xiaoxia Hu, Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lü, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Jianmin Wang, MD

Blood (2013) 122 (21): 1356.

https://doi.org/10.1182/blood.V122.21.1356.1356

Published: 2013

Journal Articles

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

Jie Jin, MD, Xin Du, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jianmin Wang, MD, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jian Hou, MD, PhD

Blood (2013) 122 (21): 3227.

https://doi.org/10.1182/blood.V122.21.3227.3227

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Annete Njue, PhD, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5099.

https://doi.org/10.1182/blood.V122.21.5099.5099

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Ann Colosia, PhD, Peter C Trask, PhD, MPH, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Annete Njue, PhD, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, Rodrigo Ruiz-Soto, MD, MSc, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5104.

https://doi.org/10.1182/blood.V122.21.5104.5104

Published: 2013

Journal Articles

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Rachel Lee Police, MPH, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Annete Njue, PhD, Jianmin Wang, PhD, MD, Sherrill Elizabeth, MS, James A. Kaye, MD, DrPH, Rodrigo Ruiz-Soto, MD, MSc, Mehdi Hamadani, MD

Blood (2013) 122 (21): 5106.

https://doi.org/10.1182/blood.V122.21.5106.5106

Published: 2013

Journal Articles

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Libing Wang, Xiaoxia Hu, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Jianmin Wang, MD

Blood (2013) 122 (21): 1379.

https://doi.org/10.1182/blood.V122.21.1379.1379

Published: 2013

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Checkpoint Immunotherapy Is Associated with Preferential Activation of Tumor-Antigen Specific CD4 + T Cells in MDS

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

β2-AR Signaling Enhances MDSC Survival through Metabolic Reprograming and Impairs Therapeutic Efficacy in Hematologic Malignancies

Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141 Hi Conventional Dendritic Cells

RNA Editing By APOBEC3A Confers Dynamic Mutational Load in Monocytic Leukemias

Patients with MDS Demonstrate Reduced Numbers and Impaired Differentiation of CD141 Hi Conventional Dendritic Cells

Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leukemia Patients with Imatinib-Resistance or -Intolerance: Results from a 6-Year Follow-up of a Multicenter Phase II Study

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only